Bromelain Market by Form (Capsule, Cream, Powder), Application (Dietary Supplements, Healthcare, Meat & Seafood) - Global Forecast 2023-2030

Bromelain Market by Form (Capsule, Cream, Powder), Application (Dietary Supplements, Healthcare, Meat & Seafood) - Global Forecast 2023-2030


The Bromelain Market is projected to reach USD 104.36 million by 2030 from USD 46.36 million in 2022, at a CAGR of 10.67% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Bromelain Market.
  • Based on Form, market is studied across Capsule, Cream, Powder, and Tablet. The Tablet is projected to witness significant market share during forecast period.
  • Based on Application, market is studied across Dietary Supplements, Healthcare, and Meat & Seafood. The Meat & Seafood is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Bromelain Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Bromelain Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Bromelain Market, highlighting leading vendors and their innovative profiles. These include AdvaCare Pharma, Advanced Enzyme Technologies Limited, Bio-gen Extracts Pvt. Ltd., Challenge Bioproducts Co., Ltd., Changsha Natureway Co., Ltd., Creative Enzymes, Enzybel Group, Enzyme Development Corporation, Enzyme Technologies, Great Food Group of Companies, Guangxi Nanning Javely Biological Products Co. Ltd., Gynemed GmbH & Co. KG, Holland & Barrett Limited, Hong Mao Biochemicals Co., Ltd., Houston Nutraceuticals, Inc., Krishna Enzytech Pvt. Ltd., Leeford Healthcare Limited, Merck KGaA, Mitushi Biopharma, Source Naturals, Inc., URSAPHARM Arzneimittel GmbH, and Xena Bio Herbals Pvt. Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Bromelain Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Bromelain Market?
  3. What is the competitive strategic window for identifying opportunities in the Bromelain Market?
  4. What are the latest technology trends and regulatory frameworks in the Bromelain Market?
  5. What is the market share of the leading vendors in the Bromelain Market?
  6. Which modes and strategic moves are suitable for entering the Bromelain Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Bromelain Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand of bromelain in healthcare and dietary supplements
5.1.1.2. Rapid adoption of bromelain skin care products
5.1.1.3. Rising prevalence of osteoarthritis and sinusitis across the globe
5.1.2. Restraints
5.1.2.1. Concern associated with side effects of bromelain usage
5.1.3. Opportunities
5.1.3.1. Ongoing research activities for bromelain-based cancer therapy
5.1.3.2. Upsurging need of enzyme-based ingredients in food and beverage sector
5.1.4. Challenges
5.1.4.1. Lack of adequate scientific proof of bromelain effectiveness and usefulness
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Bromelain Market, by Form
6.1. Introduction
6.2. Capsule
6.3. Cream
6.4. Powder
6.5. Tablet
7. Bromelain Market, by Application
7.1. Introduction
7.2. Dietary Supplements
7.3. Healthcare
7.4. Meat & Seafood
8. Americas Bromelain Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Bromelain Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Bromelain Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AdvaCare Pharma
12.1.2. Advanced Enzyme Technologies Limited
12.1.3. Bio-gen Extracts Pvt. Ltd.
12.1.4. Challenge Bioproducts Co., Ltd.
12.1.5. Changsha Natureway Co., Ltd.
12.1.6. Creative Enzymes
12.1.7. Enzybel Group
12.1.8. Enzyme Development Corporation
12.1.9. Enzyme Technologies
12.1.10. Great Food Group of Companies
12.1.11. Guangxi Nanning Javely Biological Products Co. Ltd.
12.1.12. Gynemed GmbH & Co. KG
12.1.13. Holland & Barrett Limited
12.1.14. Hong Mao Biochemicals Co., Ltd.
12.1.15. Houston Nutraceuticals, Inc.
12.1.16. Krishna Enzytech Pvt. Ltd.
12.1.17. Leeford Healthcare Limited
12.1.18. Merck KGaA
12.1.19. Mitushi Biopharma
12.1.20. Source Naturals, Inc.
12.1.21. URSAPHARM Arzneimittel GmbH
12.1.22. Xena Bio Herbals Pvt. Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings